Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

63.86

-0.63 (-0.98%)

At close: Apr 28, 2026, 4:00 PM EDT

64.20

+0.34 (0.53%)

Pre-market: Apr 29, 2026, 6:46 AM EDT

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $7.57 billion as of April 29, 2026. Its market cap has increased by 2.02% in one year.

Market Cap

7.57B

Enterprise Value

9.60B

1-Year Change

2.02%

Ranking

#1105

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $7.57B, an increase of 93,304.55%. That is a compound annual growth rate of 36.21%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	7.54B	-4.77%
Dec 31, 2025	7.91B	30.11%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ABIVAX Société Anonyme	8.90B
Vaxcyte	8.56B
Bio-Techne	8.48B
Nuvalent	8.22B
Cytokinetics	8.12B
Krystal Biotech	8.02B
ImmunityBio	7.68B
Kymera Therapeutics	6.93B

Market Cap Rankings